Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Effect of Lecanemab and Donanemab in Early Alzheimer’s Disease: Mechanistic Interpretation in the Amyloid Cascade Hypothesis 2.0 Perspective

Journal of Alzheimer s Disease(2023)10.3233/jad-230164Source: DataRank Database

Effect of Lecanemab and Donanemab in Early Alzheimer’s Disease: Mechanistic Interpretation in the Amyloid Cascade Hypothesis 2.0 Perspective is a research paper published in Journal of Alzheimer s Disease (2023). On theSindex it has a DataRank of 0. It has been cited 38 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access38 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 5.42)OA: bronzeTopics (30)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Sophia Rits‐Volloch ORCID,Vladimir Volloch

Live enrichment

PubMed:37212119 PMC:PMC10357217 OpenAlex:https://openalex.org/W4377116102

NIAMS NIH HHS

Grant: R01 AR036819

NIGMS NIH HHS

Grant: R21 GM056179

FWCI

5.42

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

bronzeLicense: cc-by-nc

journalhttps://content.iospress.com:443/download/journal-of-alzheimers-disease/jad230164?id=journal-of-alzheimers-disease%2Fjad230164

publisherhttps://content.iospress.com:443/download/journal-of-alzheimers-disease/jad230164?id=journal-of-alzheimers-disease%2Fjad230164

publisherhttps://journals.sagepub.com/doi/pdf/10.3233/JAD-230164

publisherhttps://journals.sagepub.com/doi/full-xml/10.3233/JAD-230164

journalhttps://doi.org/10.3233/jad-230164

Fields of Study

Alzheimer's disease research and treatmentsComputational Drug Discovery MethodsCholinesterase and Neurodegenerative Diseases

MeSH Terms

Alzheimer DiseaseAmyloidHumansAmyloid beta-PeptidesAmyloidogenic ProteinsAntibodies, Monoclonal, Humanized

Keywords

Perspective (graphical)DiseaseAmyloid βPsychologyCascadeBiochemistry of Alzheimer's diseaseClinical trialAlzheimer's diseaseCognitive psychologyMedicineNeuroscienceComputer scienceArtificial intelligenceInternal medicineAmyloid precursor proteinAlzheimer’s diseaseIntraneuronal AβDonanemabLecanemabAmyloid Cascade Hypothesis 2.0Aβpp-independent Iaβ Generation In Ad